DoseSpot, a software-as-a-service platform that allows clinicians to electronically write and transmit prescriptions to pharmacies and portfolio company of PSG, has acquired the TreatRX segment of Bravado Health.

The deal is intended to strengthen and expand DoseSpot’s service offerings for healthcare providers and enhance its position in the e-prescription software integration market. Bravado Health’s existing e-prescription customers will be supported through the transition and will benefit from added resources and capabilities.

“We’re thrilled to welcome TreatRx to the DoseSpot community,” says Josh Weiner, CEO of DoseSpot. “This acquisition represents a significant milestone for us as we continue to invest in and expand our ePrescribing platform. By incorporating Bravado Health’s ePrescribing technology and expertise, we can offer even more value to our current and future customers, helping them to practice safe prescribing, increase practice efficiency, and stay compliant with state and federal mandates.”